Log In Sign Up

Trading

Trading

Browse Companies

Data

Data

IPO Stock Tracker

Solutions

Solutions

For Institutions

For Shareholders

Insights

Insights

Popular Topics

Buying Pre-IPO Shares

Selling Pre-IPO Shares

Private Market Reports

Private Market Data & Analytics

About

About

Investor Relations

People & Culture

Freeline Therapeutics Stock

freeline.lifeHealthcareFounded: 2015Funding to Date: $205.53MM

Freeline is a clinical-stage, fully integrated, next generation, systemic AAV-based gene therapy company with the ambition of transforming the lives of patients suffering from inherited systemic debilitating diseases.

Learn more about Freeline Therapeutics IPO

Overview Financings Valuation

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Freeline Therapeutics.

Register Today

Team

Management Team

Brian Silver JD

Chief Financial Officer & Head of Corporate Development

Karen Law

Executive

Natalia Misciattelli

Senior Vice President, Strategy and Business Operations

Markus Horer Ph.D

Co-Founder, Chief Technology Officer & Managing Director

Jane Whitrow Ph.D

Vice President, Finance & Company Secretary

Jan Thirkettle Ph.D

Chief Development Officer

Amit Nathwani

Co-Founder, Chief Scientific Officer & Board Member

Gerard Short

Senior Vice President, Head of Clinical and Regulatory

Romuald Corbau Ph.D

Vice President, Research

Board Members

Christopher Hollowood Ph.D

Syncona

Amit Nathwani

Martin Andrews

Jeffrey Chodakewitz MD

Other companies like Freeline Therapeutics in the Healthcare sector

Sector

Last Round Est. Valuation

$2.15B

Colossal Biosciences

Sector

Sector

Last Round Est. Valuation

$3.67B

Sector

Last Round Est. Valuation

$400.53MM

Sector

Last Round Est. Valuation

$4.26B

Sector

Mammoth Biosciences

Sector

Last Round Est. Valuation

$1.08B

Sector

Precision Neuroscience

Sector

Frequently Asked Questions